Diagnostics Therapeutics Genetic Signature to Predict NAC Efficacy in Treating Idiopathic Pulmonary Fibrosis (IPF) N-Acetylcysteine (NAC) is commonly used to break down mucous and lessen lung function decline but has traditionally shown low efficacy in treating patients with… Interests: Genomics Reference ID: 15-T-034 Desired Partnership: Co-development, Licensing IP: Patent Pending
Diagnostics Therapeutics Neurophysiological Biomarker for Early ALS Detection Presently, physicians rely on a costly and invasive battery of tests for diagnosing ALS. Early detection of ALS can improve patient survival and quality… Interests: Healthcare IT, Neurology Reference ID: 18-T-074 Desired Partnership: Co-development, Investment, Licensing IP: Patent Pending
Diagnostics Patient Microbiota As A Predictive Biomarkers For Response To Checkpoint Blockade Therapy Improved prediction of patient response to checkpoint blockade immunotherapy through identification of specific gut microbiota biomarkers, thereby enhancing clinical decision-making and treatment efficacy in… Interests: Biomarker Reference ID: 17-T-051
Diagnostics Therapeutics A Prognostic Signature For Breast Cancer This prognostic signature for breast cancer improves patient survival outcomes by assessing the coordinated regulation of HMGA2, TET1, and HOXA9 expression to guide targeted… Interests: Drug Screening, Oncology Reference ID: 13-T-081
Diagnostics Therapeutics c-CBL Mutations Predict Lung Cancer Sensitivity to Chemotherapeutic Agents that Target EGFR and MET A diagnostic technology that enables prediction of lung cancer sensitivity to targeted chemotherapeutic agents by identifying specific c-CBL gene mutations, thus facilitating more effective… Interests: Drug Screening, Oncology, Oncology Solid Tumor Reference ID: 10-T-070
Diagnostics Medical Devices AuNP-DG: Deoxyglucose Labeled Gold Nanoparticles as X-Ray Computed Tomography Contrast Agents for Cancer Imaging The targeted metabolic imaging enhancement achieved by deoxyglucose-labeled gold nanoparticles (AuNP-DG) offers superior tumor-specific contrast and improved resolution in computed tomography (CT) scans compared… Interests: Imaging, Imaging Agents, Oncology Radiotherapy, Oncology Solid Tumor Reference ID: 09-T-081
Diagnostics Research Tools A Versatile and High-throughput Assay for the Directed Evolution of Reverse Transcriptases to Profile Epigenetic Modifications With NGS Engineered reverse transcriptases (RTs) to profile epigenetic modifications have numerous advantages over traditional antibody enrichment methods including: single base pair resolution, lower sample quantities… Interests: Tangible Property Reference ID: 18-T-669 Desired Partnership: Licensing IP: Tangible property
